A 1207 New Jersey General Assembly · 2024-2025 Regular Session

Requires health insurance coverage of prescribed anti-obesity medication.

This bill requires most health insurance plans in New Jersey to cover prescribed, FDA-approved anti-obesity medication for chronic weight management. It applies to all health insurance contracts (including hospital service corporations, medical service corporations, HMOs, and state-administered programs) issued or renewed in the state after its effective date. The coverage must be provided at the same level as treatment for other medical conditions, with no separate restrictions or higher out-of-pocket costs. It directly affects New Jersey residents with health insurance who are prescribed these medications for obesity, which the bill defines as FDA-approved drugs for chronic weight management.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024 Last action Jan 9, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Assembly, Referred to Assembly Health Committee
lower
2 primary · 0 co-sponsors

Sponsors